University College London Hospitals — CureCurrent

How to interpret these research links

Connected source records

The exact organization name University College London Hospitals appears in 58 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials58

Recruiting shown11

Roles2

SourceClinicalTrials.gov

Clinical trials

58 shown

Feasibility Trial of ScarWork for Post-breast Surgery Pain Syndrome.NCT07206394 · lead sponsor · 2025-06-20

An Observational Study of Predictors and Outcomes of Lung Cancer in Never-smokers in the UKNCT06575439 · lead sponsor · 2024-09-17

PD Frontline (Part of RAPSODI GD) Remote Assessment of People With Parkinson'sNCT06151002 · lead sponsor · 2020-02-15

Prostate Cancer Genomic HeterogeneityNCT02022371 · lead sponsor · 2014-09-01

FOcal RECurrent Assessment and Salvage TreatmentNCT01883128 · lead sponsor · 2014-04-01

Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in MenNCT02033447 · lead sponsor · 2013-12-01

Focal Therapy for Localised Prostate Cancer Using Irreversible ElectroporationNCT01726894 · lead sponsor · 2013-10-01

Imaging for Significant Prostate Cancer Risk EvaluationNCT01492270 · lead sponsor · 2011-12-01

MRI in Diagnosing Prostate CancerNCT01292291 · lead sponsor · 2011-04-01

Study of Treatment Choice in Patients With Localized Prostate CancerNCT01177865 · lead sponsor · 2010-09-01

Study to Prevent Radiation Induced Damage to Bowel Using a Prebiotic Enhanced Diet.NCT01414517 · lead sponsor · 2010-08-01

Dutasteride in Treating Patients With Prostate CancerNCT01193855 · lead sponsor · 2010-06-01

Assessment of the Clinical Efficacy and Acceptability of Think Positive (T+) in Diabetes ManagementNCT00922376 · lead sponsor · 2010-06-01

High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate CancerNCT00988130 · lead sponsor · 2009-07-01

High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate CancerNCT00987675 · lead sponsor · 2009-07-01

A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY)NCT00932854 · lead sponsor · 2009-07-01

A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST)NCT00652769 · lead sponsor · 2008-03-01

High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate CancerNCT00561314 · lead sponsor · 2007-07-01

High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate CancerNCT00561262 · lead sponsor · 2006-05-01

A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple SclerosisNCT00257855 · lead sponsor · 2005-11-01

Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast CancerNCT00321633 · lead sponsor · 2005-09-01

The Role of Diet and Lifestyle in Breast Cancer SurvivalNCT00701584 · lead sponsor · 2005-01-01

Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast CancerNCT00691509 · lead sponsor · 2005-01-01

Breathing and Relaxation Exercises for Asthma: a Randomised Controlled TrialNCT00400270 · lead sponsor · 2004-10-01

PRostate Cancer Enhanced Diagnosis by Calibration TechnologyNCT06607783 · collaborator · 2026-06-26

Harnessing Male Peer Networks to Enhance Engagement With HIV PreventionNCT06370923 · collaborator · 2024-10-21

Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance)NCT06280781 · collaborator · 2024-05-24

Optimising Azithromycin Prevention Treatment in COPD to Reduce ExacerbationsNCT05772013 · collaborator · 2024-03-05

The STOP-MED CTRCD TrialNCT06183437 · collaborator · 2024-03-04

Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis StudyNCT05432739 · collaborator · 2021-04-07

A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLCNCT04550104 · collaborator · 2021-03-17

Periodontal Assessment of a Bariatric Care PopulationNCT04851470 · collaborator · 2014-01-31

Advanced Diffusion Magnetic reSonance Prostate Imaging for Reducing Extraneous Biopsies (ASPIRE) - Calibration Component (Multi-centre Scanner Calibration) and Validation Component (Multi-centre Validation)NCT07808528 · collaborator · 2026-09-01

NOT_YET_RECRUITING

A Study on Remote Health Support for Patients With Heart Failure.NCT07440472 · collaborator · 2026-03-01

NOT_YET_RECRUITING

Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal MicroscopyNCT06398470 · collaborator · 2024-05-15

Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac DysfunctionNCT05880160 · collaborator · 2023-07-14

THIRST Alert TrialNCT05869656 · collaborator · 2023-05-03

A Study Comparing the Health Effects of Two Diets Following UK Dietary Guidance in People Living With Overweight or ObesityNCT05627570 · collaborator · 2023-03-01

A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected AdultsNCT04844775 · collaborator · 2022-08-05

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)NCT04120415 · collaborator · 2022-06-21

Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of CancerNCT05533515 · collaborator · 2022-02-08

Lung Nodule Imaging Biobank for Radiomics and AI ResearchNCT04270799 · collaborator · 2020-06-01

The Expressive Writing in Bariatric SurgeryNCT04035512 · collaborator · 2019-08-01

The SUMMIT Study: A Cancer Screening StudyNCT03934866 · collaborator · 2019-04-08

ACTIVE_NOT_RECRUITING

Views on Physical Activity Following a Relapse in People With Multiple SclerosisNCT03736902 · collaborator · 2018-11-13

Regulation of Lipid Metabolism in Autoimmune Disease: Multiple SclerosisNCT04053374 · collaborator · 2018-09-01

Evaluating the Effects of Frozen Section Technology on Oncological and Functional Outcomes at Radical Prostatectomy.NCT03317990 · collaborator · 2018-04-09

ACTIVE_NOT_RECRUITING

Home Testing of Day and Night Closed Loop With Pump Suspend FeatureNCT02523131 · collaborator · 2016-05-01

PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not?NCT02380027 · collaborator · 2016-01-01

Lung Screen Uptake TrialNCT02558101 · collaborator · 2015-11-02

Exercise Training as a Novel Primary Therapy for Men With Localised Prostate CancerNCT02409212 · collaborator · 2015-05-01

D-mannose for the Prevention of UTIs in Multiple SclerosisNCT02490046 · collaborator · 2015-02-01

PRIME - PRostate Imaging for Margin EvaluationNCT02151097 · collaborator · 2014-11-01

Cardiac Assessment of Patients With Hip ImplantsNCT02331264 · collaborator · 2014-11-01

Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home SettingNCT01778348 · collaborator · 2013-12-01

The Impact of an Investment Based Intervention on Weight-loss and Beliefs About Food in Patients Post Bariatric SurgeryNCT02045628 · collaborator · 2013-11-01

Single Pulmonary Nodule InvestigationNCT02013063 · collaborator · 2012-08-01

Alternative Delivery of Dose Adjustment For Normal Eating (DAFNE) Trial in Patients With Type 1 DiabetesNCT01069393 · collaborator · 2010-06-01

Drugs studied in this sponsor's trials

7 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University College London Hospitals as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

carboplatin1

docetaxel1

durvalumab1

dutasteride1

lamotrigine1

olaparib Oral Tablet [Lynparza]1

placebo1

carboplatin RxCUI 40048 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial docetaxel RxCUI 72962 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial durvalumab RxCUI 1919503 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial dutasteride RxCUI 228790 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial lamotrigine RxCUI 28439 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial olaparib Oral Tablet [Lynparza] RxCUI 1942484 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial placebo RxCUI 8375 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial

Sponsor roles

collaborator34

lead sponsor24

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.